SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-011314
Filing Date
2019-02-28
Accepted
2019-02-28 07:14:01
Documents
8
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 6-K a19-5562_16k.htm 6-K 17628
2 EX-99.1 a19-5562_1ex99d1.htm EX-99.1 82366
3 GRAPHIC g55621mm01i001.jpg GRAPHIC 2117
4 GRAPHIC g55621mm01i002.jpg GRAPHIC 2114
5 GRAPHIC g55621mm01i003.jpg GRAPHIC 2114
6 GRAPHIC g55621mm03i001.jpg GRAPHIC 2117
7 GRAPHIC g55621mm03i002.jpg GRAPHIC 2113
8 GRAPHIC g55621mm03i003.jpg GRAPHIC 2114
  Complete submission text file 0001104659-19-011314.txt   119515
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 19640397
SIC: 2836 Biological Products, (No Diagnostic Substances)